-
2026-02-25 22:00
-
2026-02-25 19:30
-
2026-02-25 03:30
Nabsys and the Research Lab of Dr. Martin Taylor, Brown University, Present Data Using the OhmX™ Platform at AGBT 2026PROVIDENCE, R.I., Feb. 25, 2026 /PRNewswire/ -- Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping (EGM) technology, today announced new findings pr
-
2026-02-20 00:00
-
2026-02-19 21:28
The two newly added countries to the survey, Qatar and Argentina, show different awareness: Qatar is among the leaders (67%), while Argentina has still margins to improve public perception on the role of energy transitionThe study has now reached over 2,300 interviews from 14 cou
-
2026-02-17 22:12
BENGALURU, India, Feb. 17, 2026 /PRNewswire/ -- Infosys(NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next generation digital services and consulting, today unveiled its AI first value framework to help global enterprises unlock AI value at scale, harnessing the power o
-
Infosys and Anthropic Announce Collaboration to Unlock AI Value across Complex, Regulated Industries2026-02-17 14:20
Collaboration launches in telecommunications with dedicated Anthropic Center of Excellence, expanding across financial services, manufacturing, and software developmentInfosys Topaz™and Anthropic's Claude models, including Claude Code, combine to automate complex workflows, accel
-
2026-02-13 10:00
Offers tailored 1-on-1 skin analysis and expert-guided drugstorecuration with up to 38% launch discountExpanding lifestyle-driven travel content that helps visitors experience Korea in a more personal waySEOUL,South Korea, Feb. 13, 2026 /PRNewswire/ --NOL World, the premier South
-
2026-02-13 08:10
Elliott does not intend to tender its shares into the Extended TOB at the current termsElliott strongly encourages other shareholders not to tender and to withdraw any shares already tenderedLONDON, Feb. 13, 2026 /PRNewswire/ -- Elliott Investment ManagementL.P. and Elliott Advis
-
2026-02-12 17:00
ZUG, Switzerland, Feb. 12, 2026 /PRNewswire/ -- Berlin Heals HoldingAG, a MedTech company focused on transformative therapies for heart failure, today announced the successful closing of a new financing round, raising over 10M USD from a combination of existing shareholders and n